A QTc study of cabazitaxel in patients with advanced solid tumors

被引：0
|
作者：
Wade, James Lloyd
Dakhil, Shaker R.
Baron, Ari David
Rottey, Sylvie
Millard, Frederick E.
Daugaard, Gedske
Machiels, Jean-Pascal H.
Conkright, William A.
Sharma, Sunil
Soetekouw, Patricia M. M. B.
Yachnin, Jeffrey
Sengelov, Lisa
van Veldhuizen, Peter
Agarwala, Sanjiv S.
Nguyen, T. X. Quyen
Chadjaa, Mustapha
Maison-Blanche, Pierre
机构：
[1] Canc Care Specialists Cent Illinois, Decatur, IL USA
[2] Canc Ctr Kansas, Wichita, KS USA
[3] Calif Pacific Med Ctr, San Francisco, CA USA
[4] Ghent Univ Hosp, Ghent, Belgium
[5] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[6] Rigshosp, DK-2100 Copenhagen, Denmark
[7] Catholic Univ Louvain, Ctr Canc, B-1200 Brussels, Belgium
[8] Purchase Canc Grp, Paducah, KY USA
[9] Huntsman Canc Inst, Salt Lake City, UT USA
[10] Univ Hosp Maastricht, Maastricht, Netherlands
[11] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[12] Herlev Hosp, DK-2730 Herlev, Denmark
[13] Kansas City Vet Adm Med Ctr, Kansas City, MO USA
[14] St Lukes Canc Ctr, Bethlehem, PA USA
[15] Sanofi, Paris, France
[16] Hop Lariboisiere, F-75475 Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.257
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
257
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
    Zhou, Xiaofei
    Richardson, Debra L.
    Dowlati, Afshin
    Goel, Sanjay
    Sahebjam, Solmaz
    Strauss, James
    Chawla, Sant
    Wang, Ding
    Mould, Diane R.
    Samnotra, Vivek
    Faller, Douglas, V
    Venkatakrishnan, Karthik
    Gupta, Neeraj
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (03): : 257 - 266
  • [42] Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure-QTc in patients with advanced or refractory solid tumors
    Valade, Elodie
    Dosne, Anne-Gaelle
    Xie, Hong
    Kleiman, Robert
    Li, Lilian Y.
    Perez-Ruixo, Juan Jose
    Ouellet, Daniele
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (03) : 621 - 633
  • [43] Concentration-QTc modeling of sitravatinib in patients with advanced solid malignancies
    Dickinson, Adam
    Liu, Yong
    Uvarov, Artem
    Peyret, Thomas
    Marier, J. F.
    Chin, Curtis
    Tran, Jonathan Q.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [44] A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
    Portnow, J.
    Frankel, P.
    Koehler, S.
    Twardowski, P.
    Shibata, S.
    Martel, C.
    Morgan, R.
    Cristea, M.
    Chow, W.
    Lim, D.
    Chung, V.
    Reckamp, K.
    Leong, L.
    Synold, T. W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 505 - 514
  • [45] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Haddad, Tufia
    Qin, Rui
    Lupu, Ruth
    Satele, Daniel
    Eadens, Matthew
    Goetz, Matthew P.
    Erlichman, Charles
    Molina, Julian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1221 - 1227
  • [46] A phase I study of oral ixabepilone in patients with advanced solid tumors
    Deeken, John F.
    Marshall, John L.
    Pishvaian, Michael J.
    Hwang, Jimmy
    Ahlers, Christoph M.
    Clemens, Pamela L.
    Parker, Susan M.
    Iacono, Lisa
    LoRusso, Patricia M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1071 - 1078
  • [47] A dose escalation study of weekly docetaxel in patients with advanced solid tumors
    Kouroussis, C
    Agelaki, S
    Mavroudis, D
    Souglakos, J
    Kakolyris, S
    Kalbakis, K
    Vardakis, N
    Reppa, D
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (06) : 488 - 492
  • [48] A phase 1 study of niraparib in Japanese patients with advanced solid tumors
    Shibaki, Ryota
    Shimizu, Toshio
    Kondo, Shunsuke
    Iwasa, Satoru
    Koyama, Takafumi
    Kitano, Shigehisa
    Sato, Jun
    Shimomura, Akihiko
    Suri, Ajit
    Kase, Yoichi
    Sumino, Shuuji
    Tamura, Kenji
    Yamamoto, Noboru
    Yonemori, Kan
    ANNALS OF ONCOLOGY, 2019, 30
  • [49] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Ciner, Aaron
    Gourdin, Theodore
    Davidson, Jeff
    Parette, Mylisa
    Walker, Susan J.
    Fox, Todd E.
    Jiang, Yixing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (01) : 23 - 29
  • [50] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
12345